Board

Dr Tatjana PAVICIC

Dermatologist

Germany

Dr Tatjana Pavicic is a board certified dermatologist specializing in cosmetic surgery and aesthetic treatments with her own private practice in Munich.

She sets her specific focus on a holistic individual approach for face & body combining botulinum toxin, fillers and energy-based devices like lasers, radiofrequency technologies and micro-focused ultrasound.

She is an internationally respected speaker and trainer on advanced cosmetic dermatology and surgery. Dr. Pavicic is member of various national and international dermatologic and cosmetic societies. She is a Treasurer of the Dermatologic Aesthetic Surgery International League (DASIL), General Secretary of the International Peeling Society, Board member of IMCAS Academy, past president of the Dermocosmetic group in the Society of Dermopharmacy, past Board member of International Society of Dermatologic Surgery, and a Global Faculty member of the Merz Institute of Advanced Aesthetics.

After studying medicine at the Ludwig Maximilian University in Munich she started her dermatologic career at the “Klinik und Poliklinik für Dermatologie und Allergologie der LMU” in 2004 receiving her board certification in 2008. From 2007 till 2014 she was Head of the department for aesthetic and laser dermatology.

Dr. Pavicic has extensively published in international journals both in the dermatological and the aesthetic fields since 2001. One of her main areas of research are filler complications and combination treatments. She has been involved in multiple studies with different molecules and compounds (botulinum toxin, dermal filler, native hyaluronic acid, dermocosmetics, lasers, peels, etc.). Additionally, Dr Pavicic followed a training in medical management and marketing at Shangai and WHU in Vallendar.

IMCAS Academy International

October 7th, 2020

Anatomy on cadaver for periorbital injections - (under educational grant)

Periorbital injection on a patient

Tatjana PAVICIC's lectures (37)

Cosmeceuticals to prolong the effect of injection & microneedling procedures

Dr Tatjana PAVICIC

Tatjana PAVICIC's schedule

IMCAS Academy International

Anatomy on cadaver for periorbital injections - (*under educational grant*)

Tatjana PAVICIC's lectures (37)

Tatjana PAVICIC's publications (39)

Arterial Wall Penetration Forces in Needles versus Cannulas.

Age and Gender Differences of the Frontal Bone: A Computed Tomographic (CT)-Based Study.

The Anatomy behind Adverse Events in Hand Volumizing Procedures: Retrospective Evaluations of 11 Years of Experience.

Precision in Dermal Filling: A Comparison Between Needle and Cannula When Using Soft Tissue Fillers.

Communication Concepts for Prevention and Early Intervention in Aesthetic Medicine: Consensus and Literature Review.

First Consensus on Primary Prevention and Early Intervention in Aesthetic Medicine.

PAN-ASIAN CONSENSUS-Key Recommendations for Adapting the World Congress of Dermatology Consensus on Combination Treatment with Injectable Fillers, Toxins, and Ultrasound Devices in Asian Patients.

An Update on the Anatomy of the Forehead Compartments.

Consensus Recommendations for Combined Aesthetic Interventions Using Botulinum Toxin, Fillers, and Microfocused Ultrasound in the Neck, Décolletage, Hands, and Other Areas of the Body.

Tempering Patient Expectations and Working With Budgetary Constraints When It Comes to a Single Versus a Multimodal Approach.

Consensus Recommendations for Combined Aesthetic Interventions in the Face Using Botulinum Toxin, Fillers, and Energy-Based Devices.

High-definition optical coherence tomography and reflectance confocal microscopy in the in vivo visualization of a reaction to permanent make-up.

Quantitative evaluation of the onset and longevity of the action of incobotulinumtoxinA by skin displacement analysis in the treatment of glabellar frown lines.

Dermal fillers in aesthetics: an overview of adverse events and treatment approaches.

Calcium hydroxylapatite filler: an overview of safety and tolerability.

A novel, multistep, combination facial rejuvenation procedure for treatment of the whole face with incobotulinumtoxinA, and two dermal fillers- calcium hydroxylapatite and a monophasic, polydensified hyaluronic acid filler.

Recommendations for the best possible use of botulinum neurotoxin type a (Speywood units) for aesthetic applications.

[Emerging strategies for the prevention and therapy of excessive scars].

[Modern soft tissue augmentation--away from treating the single fold to volume replacement in the whole face].

[Medicine for youth and beauty: smoothing folds and scars].

Efficacy of cream-based novel formulations of hyaluronic acid of different molecular weights in anti-wrinkle treatment.

Efficacy and tolerability of a new monophasic, double-crosslinked hyaluronic acid filler for correction of deep lines and wrinkles.

[Botulinum toxin--the all-rounder in medicine].

[Management of hypertrophic scars and keloids].

Monophasic, cohesive-polydensified-matrix crosslinking-technology-based hyaluronic acid filler for the treatment of facial lipoatrophy in HIV-infected patients.

Expert guideline on the use of porcine collagen in aesthetic medicine.

[Fillers. An overview].

Pimecrolimus cream (1%) efficacy in perioral dermatitis - results of a randomized, double-blind, vehicle-controlled study in 40 patients.

Anti-microbial and -inflammatory activity and efficacy of phytosphingosine: an in vitro and in vivo study addressing acne vulgaris.

Xerosis and callus formation as a key to the diabetic foot syndrome: dermatologic view of the problem and its management.

Combined aesthetic interventions for prevention of facial ageing, and restoration and beautification of face and body.

IncobotulinumtoxinA use in aesthetic indications in daily practice: a European multicenter, noninterventional, retrospective study.

Dermal fillers in aesthetics: an overview of adverse events and treatment approaches.

Complete biodegradable nature of calcium hydroxylapatite after injection for malar enhancement: an MRI study.

Botulinum toxin A for the treatment of keloids.

Botulinum toxin type A treatment to the upper face: retrospective analysis of daily practice.

Fifty-kDa hyaluronic acid upregulates some epidermal genes without changing TNF-α expression in reconstituted epidermis.

Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies.

[Evidence-based cosmetics: concepts and applications in photoaging of the skin and xerosis].

Tatjana PAVICIC's connections (56)

Tatjana PAVICIC's learned societies (4)

Tatjana PAVICIC's main interests

Anatomy on cadaver for periorbital injections - (under educational grant)